Many types of clinical trial to determine the treatment efficiency for lower-limb problems involve assessment of improvements in pain and function level. Unfortunately assessment is often hampered by qualitative results that can vary based on patient mood, physician or even the weather. Consequently, often more patients must participate than would otherwise be necessary to identify the signal amongst the noise.
GaitSmart can provide reliable, accurate, quantitative endpoint measurement to support your pharmacological science.
Changes in pain and function correlate with gait changes.
We have databases drawn from ten years of experience that show gait changes correlate with pain and function. A patient experiencing pain will not walk as well, making changes in gait the perfect surrogate marker.
GaitSmart allows portable gait analysis. Use of GaitSmart opens up a world of quantitative patient feedback in clinical trials. For example, assessment of osteoarthritis treatment, that have typically been limited to self-reported pain and function assessments.
GaitSmart's digital technology measures the movement of the calf, thigh, knee and hips in three dimensions with extraordinary accuracy (±1 deg, verified at the National Physics Laboratory). Improvement of a few degrees can be detected across 17 different parameters.